Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 10,issue 2  (01-2010)

Period of time： 2010年2期

Publisher： Bentham Science Publishers

Founded in： 2001

Total resources： 51

E-ISSN： 2212-3873|10|2

ISSN： 1871-5303

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 10,issue 2

Menu

Editorial [ Hot topic:Metabolic Syndrome - Modern Pharmacological, Genetic, Clinical and Environmental Contributions (Guest Editor: Aldi T. Kraja)]

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 10,issue 2 , Vol. 10, Iss. 2, 2010-06 , pp. 84-85

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

The Genetics of Obesity and the Metabolic Syndrome

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 10,issue 2 , Vol. 10, Iss. 2, 2010-06 , pp. 86-108

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Molecular Determinants of the Cardiometabolic Phenotype

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 10,issue 2 , Vol. 10, Iss. 2, 2010-06 , pp. 109-123

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Diet and Metabolic Syndrome

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 10,issue 2 , Vol. 10, Iss. 2, 2010-06 , pp. 124-137

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Fenofibrate and Metabolic Syndrome

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 10,issue 2 , Vol. 10, Iss. 2, 2010-06 , pp. 138-148

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

A Broad Variety of Antigens Contribute to the Pathogenesis of Atherosclerosis: How to Neutralize Noxious Reactions in the Host

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 10,issue 2 , Vol. 10, Iss. 2, 2010-01 , pp. 149-160

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Interferon-beta Inhibits Th17 Cell Differentiation in Patients with Multiple Sclerosis

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 10,issue 2 , Vol. 10, Iss. 2, 2010-06 , pp. 161-167

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

WNT4 Signaling in Female Gonadal Development

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 10,issue 2 , Vol. 10, Iss. 2, 2010-06 , pp. 168-174

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Bowel Habit in Preterm New borns: Effect of New Formulas

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 10,issue 2 , Vol. 10, Iss. 2, 2010-06 , pp. 175-178

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

How Close are We in Achieving Safe, Affordable and Reversible Male Contraceptives?

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 10,issue 2 , Vol. 10, Iss. 2, 2010-06 , pp. 179-187

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Total 10 item(s)